MAG & More

MAG & More operates in the medical technology and neuromodulation market, with a focused offering of transcranial magnetic stimulation equipment rather than a broad portfolio of unrelated devices. Its products span therapeutic systems, a research stimulator, neuronavigation, and stimulation coils, allowing it to address both clinical and research applications. The company highlights German manufacturing, an ISO 13485-aligned quality management system, medical-device safety requirements for its PowerMAG stimulators, and service and training for distribution partners as differentiators. These attributes suggest a business centered on specialized hardware, product quality, and customer support. It is part of neurocare group AG, a relationship established in 2021, which places it within a broader neurocare organization. Overall, MAG & More’s described position is that of a specialist TMS equipment developer and manufacturer serving both therapy and research users, with differentiation based on its dedicated product range and manufacturing and service approach.

MAG & More’s known development path is that of a specialist medical-device manufacturer founded in 2002 and focused on transcranial magnetic stimulation systems, coils, and related tools. Its inclusion in neurocare group AG in 2021 is the clearest identifiable inflection point in the available company history. The product portfolio spans therapeutic systems such as Apollo TMS and PowerMAG Touch, the PowerMAG Research stimulator, PowerMAG View neuronavigation, and magnetic stimulation coils. This breadth indicates coverage of several related use cases, from therapy delivery to research and navigation, but does not by itself establish sales growth or adoption. Its stated emphasis on German manufacturing, medical-device quality practices, tailored service, and distributor training points to a model that supports specialized equipment sales and customer relationships. Further assessment of trajectory would require measurable updates on product releases, geographic expansion, staffing, or commercial performance; none can be stated here without unsupported assumptions.